Skip to Content

Rule

Viruses, Serums, Toxins, and Analogous Products; Packaging and Labeling

Document Details

Information about this document as published in the Federal Register.

Enhanced Content

Relevant information about this document from Regulations.gov provides additional context. This information is not part of the official Federal Register document.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

AGENCY:

Animal and Plant Health Inspection Service, USDA.

ACTION:

Final rule; technical amendment.

SUMMARY:

In a final rule published in the Federal Register on August 30, 2016, and effective on October 31, 2016, we amended the Virus-Serum-Toxin Act regulations to make veterinary biologics labeling requirements more consistent with current science and veterinary practice. However, we inadvertently removed a requirement for an indications statement that should appear on final container labels, carton labels, and enclosures. This document corrects that error.

DATES:

Effective November 8, 2016.

Start Further Info

FOR FURTHER INFORMATION CONTACT:

Dr. Donna Malloy, Operational Support Section, Center for Veterinary Biologics, Policy, Evaluation, and Licensing, VS, APHIS, 4700 River Road, Unit 148, Riverdale, MD 20737; (301) 851-2352.

End Further Info End Preamble Start Supplemental Information

SUPPLEMENTARY INFORMATION:

In a final rule [1] that was published in the Federal Register on August 30, 2016 (81 FR 59427, Docket No. APHIS-2008-0008), and effective on October 31, 2016, we amended the Virus-Serum-Toxin Act regulations to make veterinary biologics labeling requirements more consistent with current science and veterinary practice. Among other things, in 9 CFR part 112, we amended § 112.2(a)(5) to clarify that “full instructions for the Start Printed Page 78500proper use of the product” refers to vaccination schedules, revaccination schedules (if necessary), indications for use, target species, recommended age for vaccination, vaccination route(s), and product license restrictions prescribed by the Animal and Plant Health Inspection Service that have a bearing on product use. However, when we made that change, we inadvertently removed a requirement for an indications statement to appear on final container labels, carton labels, and enclosures. Therefore, we are amending § 112.2(a) to re-establish the requirement for an indications statement.

Start List of Subjects

List of Subjects in 9 CFR Part 112

  • Animal biologics
  • Exports
  • Imports
  • Labeling, packaging and containers
  • Reporting and recordkeeping requirements
End List of Subjects

Accordingly, we are amending 9 CFR part 112 as follows:

Start Part

PART 112—PACKAGING AND LABELING

End Part Start Amendment Part

1. The authority citation for part 112 continues to read as follows:

End Amendment Part Start Authority

Authority: 21 U.S.C. 151-159; 7 CFR 2.22, 2.80, and 371.4.

End Authority Start Amendment Part

2. Section 112.2 is amended by adding paragraph (a)(12) to read as follows:

End Amendment Part
Final container label, carton label, and enclosure.

(a) * * *

(12) An indications statement to read, “This product has been shown to be effective for the vaccination of healthy (insert name of species) __ weeks of age or older against __.” Provided, That in the case of very small final container labels or carton, a statement as to where such information is to be found, such as “See enclosure for complete directions,” “Full directions on carton,” or comparable statement.

* * * * *
Start Signature

Done in Washington, DC, this 2nd day of November 2016.

Kevin Shea,

Administrator, Animal and Plant Health Inspection Service.

End Signature End Supplemental Information

Footnotes

1.  To view the final rule and supporting documents, go to http://www.regulations.gov/​#!docketDetail;​D=​APHIS-2008-0008.

Back to Citation

[FR Doc. 2016-26936 Filed 11-7-16; 8:45 am]

BILLING CODE 3410-34-P